Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 714,734 | 582,022 | 437,855 | 305,440 | 159,742 |
| Cost of Goods | 156,815 | 121,236 | 83,481 | 55,518 | 27,738 |
| Gross Profit | 557,919 | 460,786 | 354,374 | 249,922 | 132,004 |
| Operating Expenses | 367,908 | 268,992 | 234,669 | 162,912 | 115,756 |
| Operating Income | 190,826 | 192,030 | 120,186 | 87,528 | 16,986 |
| Interest Expense | 17,496 | 23,757 | 18,795 | 24,194 | 28,220 |
| Other Income | 18,474 | 5,123 | 3,295 | -25,906 | -25,710 |
| Pre-tax Income | 191,804 | 173,396 | 104,686 | 37,428 | -36,944 |
| Income Tax | 46,311 | 44,543 | -76,782 | 2,831 | N/A |
| Net Income Continuous | 145,493 | 128,853 | 181,468 | 34,597 | -36,944 |
| Net Income | $145,493 | $128,853 | $181,468 | $34,597 | $-36,944 |
| EPS Basic Total Ops | 2.56 | 2.17 | 3.07 | 0.60 | -2.48 |
| EPS Basic Continuous Ops | 2.56 | 2.17 | 3.07 | 0.60 | -1.43 |
| EPS Diluted Total Ops | 2.51 | 2.13 | 2.97 | 0.58 | -2.48 |
| EPS Diluted Continuous Ops | 2.51 | 2.13 | 2.97 | 0.58 | -1.43 |
| EPS Diluted Before Non-Recurring Items | 2.51 | 2.13 | 3.00 | 2.07 | 0.21 |
| EBITDA(a) | $213,377 | $215,948 | $144,802 | $108,606 | $29,635 |